gabexate has been researched along with Asystole in 2 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Luh, SP | 1 |
Tsai, CC | 1 |
Shau, WY | 1 |
Chen, JS | 1 |
Kuo, SH | 1 |
Lin-Shiau, SY | 1 |
Lee, YC | 1 |
Takemoto, Y | 1 |
Tanaka, S | 1 |
Tanabe, J | 1 |
Nakamura, Y | 1 |
Kohama, A | 1 |
Shibata, S | 1 |
2 other studies available for gabexate and Asystole
Article | Year |
---|---|
The effects of inhaled nitric oxide, gabexate mesilate, and retrograde flush in the lung graft from non-heart beating minipig donors.
Topics: Administration, Inhalation; Animals; Blood Pressure; Gabexate; Heart Arrest; Heart Rate; Hemodynamic | 2000 |
Studies on the effects of primary therapy for DIC following circulatory arrest.
Topics: Animals; Anticoagulants; Benzamidines; Blood Coagulation Tests; Disseminated Intravascular Coagulati | 1986 |